Michael S. Weiss

2017 - TG Therapeutics

In 2017, Michael S. Weiss earned a total compensation of $9.9M as Chief Executive Officer and President at TG Therapeutics, a 156% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$217,969
Salary$525,000
Stock Awards$9,183,647
Total$9,926,616

Weiss received $9.2M in stock awards, accounting for 93% of the total pay in 2017.

Weiss also received $218K in non-equity incentive plan and $525K in salary.

Rankings

In 2017, Michael S. Weiss' compensation ranked 651st out of 14,666 executives tracked by ExecPay. In other words, Weiss earned more than 95.6% of executives.

ClassificationRankingPercentile
All
651
out of 14,666
96th
Division
Manufacturing
215
out of 5,772
96th
Major group
Chemicals And Allied Products
53
out of 2,075
97th
Industry group
Drugs
37
out of 1,731
98th
Industry
Pharmaceutical Preparations
32
out of 1,333
98th
Source: SEC filing on April 30, 2018.

Weiss' colleagues

We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2017.

2017

Sean Power

TG Therapeutics

Chief Financial Officer

News

You may also like